2021
DOI: 10.1007/s13346-021-00980-z
|View full text |Cite
|
Sign up to set email alerts
|

Titanium dioxide nanotubes as drug carriers for infection control and osteogenesis of bone implants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
22
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 41 publications
(24 citation statements)
references
References 153 publications
0
22
0
Order By: Relevance
“…Drug molecules with antibacterial and osteogenic properties were loaded into TNT using various techniques, including physical adsorption, electrophoretic deposition, and magnetron sputtering. Changing the surface morphology of TNT can prolong the elution time of the drug and extend the duration of action of functional drug molecules against infection and contribute to bone regeneration ( Wang K. et al, 2021 ). Jiao et al prepared implant coatings containing BMP2 and GelMA/PMAA-Cl on TNT.…”
Section: Antibacterial-osteogenic Modifications Of Dental Implant Sur...mentioning
confidence: 99%
“…Drug molecules with antibacterial and osteogenic properties were loaded into TNT using various techniques, including physical adsorption, electrophoretic deposition, and magnetron sputtering. Changing the surface morphology of TNT can prolong the elution time of the drug and extend the duration of action of functional drug molecules against infection and contribute to bone regeneration ( Wang K. et al, 2021 ). Jiao et al prepared implant coatings containing BMP2 and GelMA/PMAA-Cl on TNT.…”
Section: Antibacterial-osteogenic Modifications Of Dental Implant Sur...mentioning
confidence: 99%
“…Wang et al describe the creation of an array of titanium dioxide nanotubes (TNTs) on the surface of titanium implants using anodic oxidation. These are proposed to be beneficial to bone ingrowth but could also be used as drug carriers to confer anti-infective properties to the material [116].…”
Section: Local Carriers and Coatingsmentioning
confidence: 99%
“…However, during treatment, patients are prone to serious healthcare-associated infections (HAIs) such as central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, peri-implants, surgical site infections, etc. 1,2 HAIs result in substantial morbidity and mortality and potentially bring about a large increase in the cost of caring for patients, and HAIs are often exacerbated by surfaces that support bacterial attachment and subsequent biofilm formation. 3−6 Biofilms are surfaceattached bacterial communities embedded in a hydrated extracellular polymeric substance (EPS) primarily composed of exopolysaccharides, proteins, and enzymes.…”
Section: ■ Introductionmentioning
confidence: 99%
“…In modern healthcare, invasive devices are extensively used in clinical practice. However, during treatment, patients are prone to serious healthcare-associated infections (HAIs) such as central line-associated bloodstream infections, catheter-associated urinary tract infections, ventilator-associated pneumonia, peri-implants, surgical site infections, etc. , HAIs result in substantial morbidity and mortality and potentially bring about a large increase in the cost of caring for patients, and HAIs are often exacerbated by surfaces that support bacterial attachment and subsequent biofilm formation. − Biofilms are surface-attached bacterial communities embedded in a hydrated extracellular polymeric substance (EPS) primarily composed of exopolysaccharides, proteins, and enzymes. , The EPS works as a guardian barrier against drug infiltrations and cellular attacks by the host innate immune system . Biofilm-induced HAIs have become one of the most prevalent and serious complications due to the ease of biofilm formation and difficulty of biofilm removal on implanted devices .…”
Section: Introductionmentioning
confidence: 99%